Labshake search
Citations for Tocris :
101 - 150 of 173 citations for Progesterone Receptor PGR Antibody since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2023Quote: ... or 10 μM TGFB receptor inhibitors including SB525334 (Selleckchem S1476) and A83-01 (Tocris 2939) were prepared according to the supplier’s instructions ...
-
bioRxiv - Neuroscience 2023Quote: ... GABAA and glycinergic receptor-mediated synaptic transmission was blocked using 50 μM picrotoxin (Tocris Bioscience), which was prepared from a 100 mM stock solution containing DMSO (final DMSO concentration ...
-
bioRxiv - Neuroscience 2020Quote: ... Substance P was manipulated by injecting the agonist of the NK-1 receptor Substance P (Tocris) to an estimated final concentration of 200 nM ...
-
bioRxiv - Neuroscience 2022Quote: ... to block ionotropic gamma-amino-butyric acid receptors (GABAARs) and 10 μM NBQX (1044, Tocris Biosciences) to inhibit α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) ...
-
bioRxiv - Neuroscience 2021Quote: ... was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Neuroscience 2021Quote: ... 3-((±)2-carboxypiperazin-4yl) propyl-1-phosphate (CPP, NMDA receptor antagonist, 20 μM; Tocris Bioscience, UK) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX ...
-
bioRxiv - Neuroscience 2022Quote: ... we slowly infused 200 nl of the GABAA receptor agonist muscimol (Tocris; 2 μM in saline) into the target area using a micro-syringe pump (KD Scientific ...
-
bioRxiv - Neuroscience 2023Quote: ... was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Neuroscience 2023Quote: ... were dissolved in HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Animal Behavior and Cognition 2023Quote: ... As a positive control we used potent agonist of CB1 and CB2 receptors CP55,940 (Tocris, UK). All doses were selected based on our previously published experiments46,50 ...
-
bioRxiv - Neuroscience 2023Quote: ... neural medium was additionally supplemented with retinoid X receptor agonist SR 11237 (100 nM; Tocris, 3411). From day 22 ...
-
bioRxiv - Bioengineering 2019Quote: ... at 2μM and at 4μM and by blocking the RyR receptors using Ryanodine (Tocris, cat no. 1329). at 10μM ...
-
bioRxiv - Neuroscience 2021Quote: ... IP3 receptors were blocked by bath application of 2-APB (100 µM, Tocris, Germany, micro-perfusion pump), 2-APB was applied at least 15 min prior t-LTP induction and was present throughout the recordings ...
-
bioRxiv - Neuroscience 2020Quote: ... EPSCs were induced in the presence of the competitive AMPA receptor antagonist NBQX (3 μM, Tocris Bioscience). Paired-Pulse stimulation for excitatory autapses was assessed by the induction of 2 action potentials with an interstimulus interval of 25 ms ...
-
bioRxiv - Neuroscience 2022Quote: ... To monitor acute changes in [Cl-]i we bath applied GABAA receptor agonist muscimol (Tocris, 10 μM) and imaged at lower resolution (every 2 minutes at a resolution of 4.1 pixels/μm (512×512 pixels ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid, a selective NMDA receptor antagonist, Tocris).
-
bioRxiv - Neuroscience 2023Quote: The AMPA receptor antagonist cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione; CNQX disodium salt; #1045; Tocris Biosciences) or 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione (DNQX disodium salt ...
-
bioRxiv - Neuroscience 2024Quote: ... EPSCs were induced in the presence of the competitive AMPA receptor antagonist NBQX (3 µM, Tocris Bioscience). Paired-Pulse stimulation for excitatory autapses was assessed by the induction of 2 action potentials with an interstimulus interval of 20 ms ...
-
bioRxiv - Neuroscience 2021Quote: ... were dissolved in magnesium-free HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Cell Biology 2021Quote: ... interleukin-1 receptor-associated kinase 1 and 4 (IRAK 1/4; IRAK 1/4 inhibitor, 0.1 μM; Tocris); TANK-binding kinase 1 (TBK1 ...
-
bioRxiv - Neuroscience 2021Quote: ... along with blockers of ionotropic glutamate receptor blockers (DNQX 10 μM and MK801 1 μM, Tocris, Bristol, UK). Wide-field fluorescence imaging of SBFI-AM-stained slices was performed using a digital live acquisition imaging system (Andor Solis version 4.30.30034.0 ...
-
bioRxiv - Neuroscience 2023Quote: ... Then a single bolus of the dopamine D2 receptor agonist sumanirole (30 μM, Tocris No.2773 Abingdon, UK) (52 ...
-
bioRxiv - Neuroscience 2024Quote: ... Mice subsequently received an intraperitoneal injection of 1 mg/kg of the D1 receptor antagonist SCH 23390 (Tocris) and were left undisturbed for 30 minutes at which time the tail-pinch procedure was repeated ...
-
bioRxiv - Neuroscience 2019Quote: ... To block NMDA receptors we used D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris, 10 μM final concentration). To block glycinergic inhibition ...
-
bioRxiv - Neuroscience 2022Quote: ... were recorded during the application of the competitive AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 20 μM, Tocris) and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Biophysics 2022Quote: ... 100 μM 2-APB blocking stretch-activated inositol triphosphate receptors (InsP3Rs) on the ER/nuclear membranes (Tocris Bioscience #1224), 100 μM CK-666 (Tocris Bioscience #3950 ...
-
bioRxiv - Neuroscience 2021Quote: ... In a subset of experiments the D1 receptor agonist (SKF81297; 20 mg/kg in saline; Tocris R&D systems), was injected intraperitoneally while recording cADDis photometry signals ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 mM QX314 was added into the intracellular pipette solution while GABAA receptor antagonist picrotoxin (PTX, 50 μM, Tocris), GABAB receptor antagonist CGP55845 (3 μM ...
-
bioRxiv - Evolutionary Biology 2023Quote: ... 0.33 mM CaCl2, 0.33 mM MgSO4) containing Smoothened inhibitor (BMS-833923, Selleckchem) or Activin receptor type 1 inhibitor (LDN 193189, TOCRIS) in 10 cm plastic dishes from 32 hpf to 72 hpf ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... were recorded at −70mV in presence of 20□μM CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione disodium, an AMPA receptor antagonist, Tocris) and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid ...
-
bioRxiv - Neuroscience 2021Quote: ... an agonist of group II metabotropic glutamate receptors (mGluR2/3) that reduces release probability in mossy fiber terminals (1 μM, Tocris)(Kamiya et al. ...
-
bioRxiv - Neuroscience 2021Quote: ... synaptic GABA currents were recorded in perfusing aCSF containing the glutamate receptor antagonist kynurenic acid (3 mM, Tocris, Ellisville, MO). Recorded neurons were initially held at −70 mV for interneurons and −60 mV for GCs and SGCs and the response to 500 milli-second positive and negative current injections were examined to determine active and passive characteristics ...
-
bioRxiv - Neuroscience 2020Quote: Current-clamp recordings were performed using an BVC-700A amplifier (Dagan, Minneapolis, USA) with standard ACSF solution at 34°C containing the GABAB-receptor blocker CGP55845 (1 µM, Tocris). Recording pipettes with a resistance of 3-5 MΩ were pulled with a DMZ universal electrode puller (Zeitz-Instruments Vertriebs-GmbH ...
-
bioRxiv - Neuroscience 2021Quote: ... Glutamatergic neurons were identified by their characteristic EPSC time course and by sensitivity of EPSC to application of glutamate receptor antagonist kynurenic acid (Tocris). Synaptic currents were acquired at 10 kHz using pClamp 10.2 software (Molecular Devices ...
-
bioRxiv - Neuroscience 2021Quote: ... In some experiments fast synaptic transmission was blocked with continuous bath-application of the AMPA receptor blocker DNQX (25 μM; Tocris), the NMDA receptor blocker D-AP5 (25 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... were dissolved in magnesium-free HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190, 40 μM; Nimodipine, Tocris, 0600 ...
-
bioRxiv - Neuroscience 2021Quote: Potassium currents were isolated pharmacologically during whole-cell voltage-clamp recordings by blocking fast sodium and calcium channels as well as ionotropic receptors for GABA and glutamate (2 µM tetrodotoxin (TTX, Tocris), 300 µM NiCl2 ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... Kinin receptors involvement in NO production by the tested peptides was assessed by selective antagonism of B1 and B2 receptors with Lys-(des-Arg9-Leu8-BK-(1-9) (B1RB) and HOE-140 (Tocris) (B2RB) ...
-
bioRxiv - Neuroscience 2020Quote: ... Pluripotent hESCs were incubated with small molecules to start the dual SMAD inhibition: BMP and TGF-b receptors were pharmacologically blocked with 100 nM LDN193189 (Stemgent) and 10 mM SB431542 (Tocris), respectively ...
-
Serotonin Modulates an Inhibitory Input to the Central Amygdala from the Ventral Periaqueductal GraybioRxiv - Neuroscience 2022Quote: ... the ability of 5HT2C receptors to modulate GABA release from this pathway following fear learning was investigated by administering the 5HT2C receptor antagonist SB242084 (Tocris, Minneapolis ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... 0.3 or 1 mg/kg of the mGlu2/3 receptor agonist LY379268 (Cat No.: 2453, Batch No.: 9B/232416, CAS No.: 191471-52-0, Tocris Bioscience ...
-
bioRxiv - Neuroscience 2023Quote: ... were dissolved in HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190, 40 µM; Nimodipine, Tocris, 0600 ...
-
bioRxiv - Neuroscience 2023Quote: ... sIPSC recordings were performed in voltage clamp mode in the presence of 20 μM AMPA/Kainate receptor antagonist CNQX (Tocris) and 50 μM NMDA receptor antagonist AP5 (Tocris) ...
-
bioRxiv - Developmental Biology 2023Quote: ... The average baseline EPSP was established with a minimum of 20 sweeps before adding glutamate receptor antagonists (10 μM NBQX (Tocris) and 10 μM CPP (Tocris) ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 μM 6-Imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531; GABAA receptor antagonist, all from Tocris). The resting membrane potential was measured after whole-cell configuration was achieved ...
-
bioRxiv - Neuroscience 2024Quote: ... another group of animals received an ip injection of WIN55,212-2 (0.5 mg/kg) along with CB1 receptor antagonist SR141716A (0.5 mg/kg, ip) (Tocris Bioscience, Bristol, UK). Rats were randomly selected for each group ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... were recorded at −70 mV and isolated by using the GABAA receptor blocker gabazine 10 mM (SR 95531 hydrobromide; Tocris).
-
bioRxiv - Neuroscience 2023Quote: ... we recorded at −70mV for 48s and for 24s in the presence of the AMPA-receptor antagonist NBQX (3μM) (Tocris Bioscience) diluted in extracellular solution ...
-
bioRxiv - Neuroscience 2021Quote: ... DIV12-13 neurons were pre-treated for 20 minutes with 40 ng/ml of the CXCR2 (CXCL1 receptor in neurons) antagonist SB225002 (Tocris Bioscience), prior to the addition of 40 nM recombinant mouse CXCL1 (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: The contribution of activity-dependent incorporation of GluA1 subunit containing AMPA receptors to expression of low repeat t-LTP was verified by postsynaptic application of Pep1-TGL (100 µM, Tocris, Germany) via the patch pipette solution ...